Clever Culture Systems Limited · ASX:CC5

Clever Culture Systems — Shareholder Meeting (November 2025)

9 slides from Clever Culture Systems's shareholder meeting presentation, Nov 17, 2025

  1. Slide 1: Managing Director's Presentation – 2025 AGM

    Clever Culture Systems Ltd 16 Anster St Adelaide SA 5000 www.cleverculturesystems.com ASX:CC5 MANAGING DIRECTOR’S PRESENTATION – 2025 AGM Adelaide, Australia, 17 November 2025: Leaders in AI microbiology automation, Clever Culture Systems Ltd (ASX: CC5) is pleased to provide the attached Managing Di

  2. Slide 2: Revolutionising microbial quality control in pharmaceutical manufacturing

    ASX: CC5 For personal use only Revolutionising microbial quality control in pharmaceutical manufacturing Annual General Meeting Brent Barnes, CEO and Managing Director 17 November 2025 Clever Culture Systems ASX: CC5 1

  3. Slide 3: Disclaimer

    Disclaimer This document contains certain forward-looking statements that involve risks and uncertainties. Although we believe that the expectations reflected in the forward-looking statements are reasonable at this time, we can give no assurance that these expectations will prove to be correct. Giv

  4. Slide 4: Snapshot

    Snapshot Blue-chip customers underpin FY25 profit - $1.7m Qualified leads: ~$75m upfront sales, $15m recurring revenue* For personal use only Industry leaders backing APAS® technology with global adoption - land and expand sales strategy Commercial AstraZeneca, Bristol Myers Squibb, Pfizer, Novo Nor

  5. Slide 5: Problem

    Problem Millions of culture plates are manually Incorrect results costly read and reported annually during pharmaceutical manufacturing High cost of failure Up to US$1bn lost revenue1 For personal use only Failed results in pharmaceutical manufacturing can lead to substantial revenue losses. Catastr

  6. Slide 6: Contact plates launch: unparalleled advantage

    Product Contact plates launch: unparalleled advantage Launch Q1 FY26 to accelerate sales pipeline covering major tests For personal use only Settle Plates ~50% used Contact Plates ~50% used Automating more tests in Environmental Monitoring 90mm 55mm Passive and Active Air Sampling, Personnel Monitor

  7. Slide 7: Pipeline

    Pipeline Environmental monitoring delivered Opportunity to scale Highest volume tests automated today For personal use only Validated analysis modules (AI software): • Environmental monitoring: Settle Plates • Imaging platform reused for + Contact Plates different hardware configurations • Existing

  8. Slide 8: Experienced Board and Management

    Experienced Board and Management Delivered expansion strategy into pharmaceutical manufacturing industry For personal use only • Board and Management shareholding 20%+ Brent Barnes Rebecca Wilson CEO and MD, AU Chair, AU Aug-16 start Jul-23 start • International experience with healthcare, technolog

  9. Slide 9: Outlook

    Outlook New sales and placements with Top-20 pharma companies Sets established userbase for future sales For personal use only Growth in customers using the technology in routine operations Drives growth in recurring revenues Contact plate application provides unique value proposition for customers

Clever Culture Systems — Shareholder Meeting (November 2025) on 6ix